LLM Academy LLM Academy
Name: Towards AI Legal Name: Towards AI, Inc. Description: Towards AI is the world's leading artificial intelligence (AI) and technology publication. Read by thought-leaders and decision-makers around the world. Phone Number: +1-650-246-9381 Email: pub@towardsai.net
228 Park Avenue South New York, NY 10003 United States
Website: Publisher: https://towardsai.net/#publisher Diversity Policy: https://towardsai.net/about Ethics Policy: https://towardsai.net/about Masthead: https://towardsai.net/about
Name: Towards AI Legal Name: Towards AI, Inc. Description: Towards AI is the world's leading artificial intelligence (AI) and technology publication. Founders: Roberto Iriondo, , Job Title: Co-founder and Advisor Works for: Towards AI, Inc. Follow Roberto: X, LinkedIn, GitHub, Google Scholar, Towards AI Profile, Medium, ML@CMU, FreeCodeCamp, Crunchbase, Bloomberg, Roberto Iriondo, Generative AI Lab, Generative AI Lab VeloxTrend Ultrarix Capital Partners Denis Piffaretti, Job Title: Co-founder Works for: Towards AI, Inc. Louie Peters, Job Title: Co-founder Works for: Towards AI, Inc. Louis-François Bouchard, Job Title: Co-founder Works for: Towards AI, Inc. Cover:
Towards AI Cover
Logo:
Towards AI Logo
Areas Served: Worldwide Alternate Name: Towards AI, Inc. Alternate Name: Towards AI Co. Alternate Name: towards ai Alternate Name: towardsai Alternate Name: towards.ai Alternate Name: tai Alternate Name: toward ai Alternate Name: toward.ai Alternate Name: Towards AI, Inc. Alternate Name: towardsai.net Alternate Name: pub.towardsai.net
5 stars – based on 497 reviews

Frequently Used, Contextual References

TODO: Remember to copy unique IDs whenever it needs used. i.e., URL: 304b2e42315e

Resources

Free: 6-day Agentic AI Engineering Email Guide.
Learnings from Towards AI's hands-on work with real clients.
An LLM-based Multi-Agent Workflow for Cancer Drug Discovery
Artificial Intelligence  Latest  Machine Learning

An LLM-based Multi-Agent Workflow for Cancer Drug Discovery

Rahul V. Veettil, PhD
16 likes
August 29, 2025

Author(s): Rahul V. Veettil, PhD Originally published on Towards AI. From Target Hypothesis to Hit Proposal: A Minimal Drug Discovery Demo Triple-negative breast cancer (TNBC) is among the most aggressive forms of breast cancer. What sets TNBC apart and makes it particularly …

Read More